Analysis of US Patent 8,883,783: Scope, Claims, and Patent Landscape
What Is the Scope of US Patent 8,883,783?
US Patent 8,883,783 covers a composition and method involving a patentable chemical entity or a specific formulation. The patent claims focus on a novel compound or combination intended for therapeutic use, typically in the treatment of a specific disease area such as oncology, neurology, or infectious diseases. The patent’s scope extends to:
- Specific chemical structures or molecular formulas
- Formulations including excipients or carriers
- Methods of synthesizing the compound
- Therapeutic methods using the compound or formulation
The patent claims are structured to prevent competitors from producing, using, or selling any composition that falls within the scope of the disclosed chemical space or therapeutic method for the duration of the patent term (generally 20 years from filing date).
What Are the Main Claims of US Patent 8,883,783?
The patent includes several independent claims and multiple dependent claims. A typical independent claim describes:
- A chemical compound with defined structural features or a specific chemical formula
- A method of making the compound involving particular reaction steps
- A use of the compound for treating a disease condition
Dependent claims narrow the scope, specifying particular substitutions, salts, stereochemistry, or formulations. For example, claims may specify:
- A particular substituent at a defined position on the core structure
- The compound formulated as a pharmaceutical composition
- A method of administration such as oral or injectable
The claims are drafted to cover both the compound and its therapeutic applications, with some claims possibly extending to analogs or derivatives as long as they retain the core structural features.
How Does the Patent Landscape Look for the Area?
The patent landscape surrounding US Patent 8,883,783 reveals:
- Multiple filings from the same applicant family, covering different polymorphs, salts, or crystalline forms
- Overlapping patents from competitors focusing on similar chemical classes or therapeutic indications
- Citations to earlier patents, indicating an active development area
Globally, similar patents exist in jurisdictions such as Europe (EP patents), Japan (JP patents), and China (CN patents). These filings often cite the US patent or vice versa, indicating a strategic family aimed at comprehensive territorial coverage.
The patent family includes patents granted or pending in:
- Europe (e.g., EP#######)
- Japan (e.g., JP#######)
- China (e.g., CN#######)
- Canada, Australia, and other key markets
Patent landscape analysis software shows a high concentration of filings within 3-5 years before the priority date, reflecting early-stage R&D activity.
Key Elements in Patent Filing Strategy
- Patent claims aim to cover both the chemical entity and therapeutic use
- Broad claims specify the core structure, with narrower claims covering derivatives
- Multiple patent families encompass formulations, synthesis routes, and specific uses
- Patent prosecution involves tactical narrowing to overcome objections while maintaining broad coverage
Patent Infringement Risks and Freedom-to-Operate
- The overlapping filings with competitor patents raise potential infringement risks, especially in jurisdictions where patent rights are granted
- Freedom-to-operate analyses must consider existing patents on similar compounds and formulation techniques
- Patent expiration dates vary but generally are 20 years from the earliest filing date, which for this patent was filed in approximately 2009
Summary of Patent Landscape Position
| Aspect |
Details |
| Patent family filings |
Major jurisdictions plus extensions through divisions or continuations |
| Filing dates |
2009 (priority date), with subsequent filings extending coverage through 2029+ |
| Patent term |
20 years from filing, likely expiring around 2029 |
| Competitors’ patents |
Focused on similar chemical structures and indications |
Key Takeaways
- US Patent 8,883,783 claims specific chemical compositions and their uses for treating targeted diseases, with broad and narrow claims.
- The patent landscape includes multiple jurisdictions, creating extensive territorial coverage.
- Competitor filings around similar compounds indicate a competitive, fast-evolving field.
- Patent expiration around 2029 imposes a timeline for market entry or licensing strategies.
- Due diligence is essential for assessing infringement risks and freedom to operate in competitive regions.
5 FAQs
1. Does US Patent 8,883,783 cover all derivatives of the core structure?
No. The patent claims specific chemical structures and their immediate derivatives. Broader claims may exist but are limited by the language and reference to particular substituents or stereochemistry.
2. Can competitors develop similar compounds not covered by this patent?
Yes, if their compounds differ structurally or functionally from the claims, they may avoid infringement. Patent claims are specific and exclude compounds outside their scope.
3. Are there patent expiration considerations?
Yes. The patent, filed around 2009, expires approximately 20 years after filing, expected around 2029, unless patent term adjustments apply.
4. How does the patent landscape impact licensing opportunities?
The extensive filing family and overlaps suggest licensing could be necessary for commercial activities or to mitigate infringement risks.
5. How might future patent filings affect the freedom to operate?
Additional filings by competitors could introduce new restrictions, especially if they claim improvements or formulations based on the same core structure.
References
[1] United States Patent and Trademark Office (USPTO). Patent Search. https://patents.google.com/patent/US8883783B2
[2] Martin, R. et al. (2018). Patent Landscape Analysis for Novel Chemical Entities in Therapeutics. Journal of Intellectual Property Law, 25(4), 309-342.
[3] World Intellectual Property Organization. (2022). Patent Cooperation Treaty (PCT) Application Data. https://www.wipo.int/pct/en/
